Funding for this research was provided by:
Ministero della Salute (001)
Article History
Received: 14 December 2020
Accepted: 19 January 2021
First Online: 28 January 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: CC has received honoraria for consultancy/advisory role/speaker bureau from Pfizer, Lilly, Novartis, Roche, all outside the submitted work. SM has no potential conflicts of interest to disclose. GC served as consultant or advisor for Roche, Lilly, and Bristol-Myers Squibb, served on the speaker’s bureau for Roche, Pfizer, and Lilly, received travel funding from Pfizer and Roche, and received honoraria from Roche, Pfizer, Lilly, Novartis, and SEAGEN.